Skip to main content
Explore URMC
URMC / Labs / Foster Lab / Projects / Preclinical Evaluation of PDT

Preclinical Evaluation of PDT

Representative Publications

Preclinical Evaluation of PDT

Preclinical Evaluation of PDT

Baran TM, Foster TH. (2012 Sep 06). Fluence rate-dependent photobleaching of intratumorally administered Pc 4 does not predict tumor growth delay. Photochem Photobiol. 88, 1273-9.

T.M. Baran, B.R. Giesselman, R. Hu, M.A. Biel, and T.H. Foster. Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue. Lasers Surg. Med. 42, 728-735 (2010) [Erratum: Lasers Surg. Med. 43, 183 (2011)]. [Medline]

T.H. Foster, B.R. Giesselman, R. Hu, M.E. Kenney, and S. Mitra. Intratumor administration of the photosensitizer Pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervals. Transl. Oncol. 3, 135-141 (2010).

J. Garrier, A. Bressenot, S. Gräfe, S. Marchal, S. Mitra, T.H. Foster, F. Guillemin, and L. Bezdetnaya. Compartmental targeting for mTHPC based photodynamic treatment in vivo: correlation of efficiency, pharmacokinetics and regional distribution of apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 78, 563-571 (2010). [Medline]

S. Mitra and T.H. Foster In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6 (NPe6). Neoplasia 10, 429-438 (2008). [Medline]